Christopher Hentschel trained as a molecular biologist and has been involved in life-sciences innovation for more than 40 years. Duuring this time, he led the development of several blockbuster drugs. He is considered a thought leader in the field of product development partnerships. He is a co-founder of the Ulysses Advisory Group and has held CEO and/or CSO roles in many successful enterprises including the MRC Collabortive Centre and Celltech in the UK, Centocor in the USA and the Medicines for Malaria Venture in Geneva Switzerland. Previously he was also a Partner and Chief Scientist at Bio Istanbul in Turkey.